HIMS
StockHims & Hers Health Inc
- HQ
- US
- Sector
- Health Care
- Issued
- 2021-01-21
- Shares out.
- 231M
Performance
4 d agoKey statistics
4 d ago- Market cap
- $5.87B
- Enterprise value
- $6.63B
- P/E (annual)
- 45.76
- P/B
- 13.66
- P/S (TTM)
- 2.48
- P/S (annual)
- 2.50
- EV / EBITDA
- 176.36×
- EV / Revenue
- 2.80×
- EPS (TTM)
- −$0.10
- EPS (annual)
- $0.50
- Basic EPS (TTM)
- −$0.10
- Book value / share
- $2.38
- Gross margin
- 72.92%
- Operating margin
- -1.29%
- Net margin
- -0.56%
- Return on equity (ROE)
- -2.48%
- Return on assets (ROA)
- -0.62%
- Return on investment (ROI)
- -0.88%
- EBITDA / share
- $0.15
- Revenue / share (TTM)
- $10.38
- Revenue growth (TTM YoY)
- +32.81%
- Revenue growth (Q YoY)
- +3.77%
- Current ratio
- 1.90
- Quick ratio
- 1.61
- Debt / equity
- 1.80
- LT debt / equity
- 1.80
- Beta
- 2.42
- Volatility (3M)
- 122.04%
Analyst ratings
4 d agoEarnings
4 d agoRelated news
4 d ago- Yahoo·4 d agocompanyHims And Hers Canadian GLP 1 Push Tests Broader Wellness Subscription Thesis
Hims & Hers Health (NYSE:HIMS) has launched generic semaglutide in Canada following a key patent lapse, marking its first GLP-1 offering outside the United States. Hims & Hers Health is also expanding its Hims & Hers Benefits program, aiming to bundle access to medications with broader wellness services. Management is positioning these moves as part of a push into new international markets and more comprehensive care offerings. Hims & Hers Health, known for its telehealth platform focused...
- Yahoo·4 d agocompanyHIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform
CEO Andrew Dudum said Hims is building "an entire health ecosystem" rather than serving as a solution for a single health condition.
- Yahoo·5 d agocompanyHims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
SAN FRANCISCO, May 28, 2026--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers Benefits, adding eight new partners to the Hims & Hers exclusive program. Joining founding partners Prenuvo and Eight Sleep are Natural Cycles, MyFitnessPal, Ladder, PVOLVE Studios, HelloFresh, Factor, Flo Health, Dexcom, and iFIT - a carefully curated lineup spanning nutrition, fitness, women's health, metabolic monitoring, and connected well
- Benzinga·5 d agocompanyCVS Expands GLP-1 Options For Members, Including The Reintroduction Of Zepbound As A Covered Medication
These changes build on Caremark's industry leading efforts as a pharmacy benefits manager to explore all potential avenues that help patients get FDA-approved weight management medications at an affordable cost. Plan
- Yahoo·6 d agocompanyHims & Hers Stock Spikes -- Insider Sends Strong Signal With $1 Million Buy
Hims & Hers Stock Pops After Board Member Makes Surprise $1.2 Million Purchase
- Yahoo·6 d agocompanyHims & Hers Gains 5% on Insider Buying
Director David Wells acquires 48,400 shares
- Yahoo·6 d agocompanyHIMS vs. TEM: Which AI Healthcare Stock Offers Better Upside Now?
Hims & Hers and Tempus AI are taking different paths in AI-driven healthcare, but which stock offers stronger upside now? Let's dive in.
- Yahoo·6 d agocompanyHims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot
Hims & Hers Health shares have slumped in 2026 as the telehealth provider moves away from selling compounded GLP-1 medications.
